Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 3 24Phase 1/2 12Phase 1 9Phase NA 5Phase 4 3Phase 2/3 3

Status

Completed 10Unknown 3Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2CNS 1

Conditions

Stomach Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Colon Cancer Liver Metastasis 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Irinotecan × Clear all
NCT04393584 2021-04-13

RusGCG-01

Blokhin's Russian Cancer Research Center

Phase 2/3 Unknown
538 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms

NCT03175016 2017-06-27

DEBIRI-CRLM

Tianjin Medical University Cancer Institute and Hospital

Phase 2/3 Unknown
200 enrolled
Gastrointestinal

Colon Cancer Liver Metastasis

NCT01308632 2011-03-04

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Grupo Español de Investigación en Neurooncología

Phase 2/3 Unknown
30 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡